Skip to main content
. 2010 Dec 10;87(6):790–801. doi: 10.1016/j.ajhg.2010.10.025

Table 3.

Power Comparisons of Sequence-Based and Variant-Based Replication under Fixed Effect Model

Ratesa
Power for Replicationb
Number of Cases/Controls in Stage 1 and 2 Samples False Positive False Negative Assay Success Error Ratio Sequence-Based Variant-Based
250/250c 0 0 1 1 0.446 0.437
1% 4% 0.9 0.5 0.432 0.392
1 0.386
10% 1% 0.9 0.5 0.429 0.399
1 0.390
6.3% 5% 0.9 0.5 0.410 0.390
1 0.378
500/500c 0 0 1 1 0.666 0.658
1% 4% 0.9 0.5 0.650 0.619
1 0.607
6.3% 1% 0.9 0.5 0.652 0.623
1 0.613
10% 5% 0.9 0.5 0.632 0.619
1 0.600
2000/2000d 0 0 1 1 0.765 0.767
1% 4% 0.9 0.5 0.747 0.703
1 0.689
6.3% 1% 0.9 0.5 0.746 0.705
1 0.694
10% 5% 0.9 0.5 0.724 0.700
1 0.669
3500/3500d 0 0 1 1 0.875 0.878
1% 4% 0.9 0.5 0.872 0.841
1 0.834
6.3% 1% 0.9 0.5 0.870 0.845
1 0.835
10% 5% 0.9 0.5 0.856 0.843
1 0.825
a

Significance levels for small-scale study: αS1 = 0.05 and αS2 = 0.05.

b

Significance levels for large-scale study: αS1 = 2.5 × 10−6 and αS2 = 2.5 × 10−6.

c

The impact of different combinations of false-positive/false-negative rate, assay success rate, and genotyping and sequencing error rate ratio on the replication power is examined.

d

The power was empirically estimated based upon 10,000 replicates.